scholarly journals Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging

2010 ◽  
Vol 90 (1) ◽  
pp. 57-62 ◽  
Author(s):  
Henrik Karring ◽  
Kasper Runager ◽  
Zuzana Valnickova ◽  
Ida B. Thøgersen ◽  
Torben Møller-Pedersen ◽  
...  
2021 ◽  
Author(s):  
Shahan Mamoor

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of latent transforming growth factor beta binding protein 4, encoded by LTBP4, in cancer of the vulva. LTBP4 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).


1995 ◽  
Vol 108 (1) ◽  
pp. 323-331 ◽  
Author(s):  
L. Zhang ◽  
M.C. Rees ◽  
R. Bicknell

A highly reproducible and technically straightforward technique for the isolation and long-term culture of normal human endometrial epithelial cells is described. The essential conditions for long-term culture are that the cells be seeded onto a gelatin matrix and that ‘endothelial cell growth supplement’ be present in the culture medium. Normal endometrial epithelial cells express cytokeratins and oestrogen receptors. They may be passaged five to six times without change in properties. Growth of normal endometrial epithelial cells was stimulated by 17-beta-oestradiol and epidermal growth factor. Expression of the mRNA coding for seven polypeptide angiogenic factors, by normal endometrial epithelial, stromal and three endometrial carcinoma lines, was examined. The endometrial epithelial and stromal cells express mRNA for the polypeptide angiogenic factors, basic fibroblast growth factor, vascular endothelial cell growth factor, transforming growth factor-beta 1 and pleiotrophin, as well as the cytokine midkine. Expression of the mRNA for both vascular endothelial growth factor and midkine by normal endometrial epithelial cells showed a 2-fold increase on treatment with a physiological dose of 17-beta-oestradiol (10(−10) M) while, in contrast, the mRNA of transforming growth factor-beta 1 decreased 4-fold on treatment with 17-beta-oestradiol (10(−10) M) and was abolished by exposure to progesterone (5 × 10(−9) M). Expression of the mRNAs for angiogenic polypeptides by the endometrial carcinoma lines was more restricted.


2021 ◽  
Author(s):  
Shahan Mamoor

Breast cancer affects women at relatively high frequency (1). We mined published microarray datasets (2, 3) to determine in an unbiased fashion and at the systems level genes most differentially expressed in the primary tumors of patients with breast cancer. We report here significant differential expression of the gene encoding transforming growth factor beta receptor 2, TGFBR2, when comparing primary tumors of the breast to the tissue of origin, the normal breast. TGFBR2 mRNA was present at significantly lower quantities in tumors of the breast as compared to normal breast tissue. Analysis of human survival data revealed that expression of TGFBR2 in primary tumors of the breast was correlated with recurrence-free survival in patients with HER2+ subtype cancers, demonstrating a relationship between primary tumor expression of a differentially expressed gene and patient survival outcomes influenced by molecular subtype. TGFBR2 may be of relevance to initiation, maintenance or progression of cancers of the female breast.


2021 ◽  
Author(s):  
Shahan Mamoor

In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of transforming growth factor beta receptor 3, encoded by TGFBR3, in cancer of the vulva. TGFBR3 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).


Sign in / Sign up

Export Citation Format

Share Document